360 ONE Asset acquires stake in OneSource Specialty Pharma

360 ONE Asset has acquired a stake in OneSource Specialty Pharma, a Contract Development and Manufacturing Organization (CDMO), for an undisclosed amount. The investment will support OneSource's innovation and global expansion plans. OneSource recently raised $95 million from other investors and is preparing to list its shares on stock exchanges.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QHh09nE
via IFTTT

Read More

How long sitting hours harm your health and how to avoid it

Incorporating movement and ergonomic adjustments into your routine can counteract the harmful effects of sitting. Small, consistent changes can significantly improve your overall well-being.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rRe9Hq8
via IFTTT

Read More

About 18% of deaths in 2019 attributable to air pollution: ICMR study

A report by India's leading health research body found that air pollution caused 1.7 million deaths in 2019. This represents 18% of all deaths in the country that year. The primary cause of death was chronic obstructive pulmonary disease (COPD). The study identified industrial emissions, vehicular exhaust, and the burning of solid fuels as major contributors to air pollution.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/6uS1Cwy
via IFTTT

Read More

Project SPECS of WHO will soon be implemented in Assam

The World Health Organization (WHO) is partnering with Sri Sankaradeva Nethralaya (SSDN) to launch the SPECS project in Assam, India. This pilot program aims to provide comprehensive eye care services, focusing on refractive errors, in three districts. The initiative will leverage SSDN's community-based approach and serve as a model for WHO's global efforts to improve eye health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fSTY5bm
via IFTTT

Read More

Wockhardt chairman seeks GST exemption for antibiotics discovered in India

Wockhardt founder sought GST exemption for antibiotics discovered in India. He said this will make the drugs more affordable. The statement was made at an event to celebrate the scientific completion of the first indigenously developed antibiotic Nafithromycin. Nafithromycin is the first macrolide antibiotic in 30 years for community-acquired bacterial pneumonia.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/l5WrHTC
via IFTTT

Read More

High pollution may boost demand for respiratory drugs

"The respiratory market shows the normal seasonal trend for the anti-asthma and cough and cold segment," said Sheetal Sapale, VP, commercial, Pharmarack. "There were fewer reported cases in October 2024 compared to October 2023, hence there is de-growth in the market. The market peaks in December and January and then gradually subsides as winter loses its intensity," Sapale said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qt0vgsj
via IFTTT

Read More

Covid shots: Parents seek vaccine courts to ensure 'swift' justice

Parents of children who allegedly died from COVID-19 vaccine side effects are demanding justice and transparency in public health policies. They are calling for faster legal proceedings and a revamped system for reporting adverse events following immunization.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3HOrCEA
via IFTTT

Read More